Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)
Condition: Neovascular Age-related Macular Degeneration Interventions: Drug: Zoledronic Acid 4 MG in 5 ML Injection; Drug: Placebos Sponsor: Oslo University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials